Ryan Cross is the Senior Science Correspondent at Endpoints News. He joined the newsroom in 2023 after covering biotech for The Boston Globe. Before that he was at Chemical & Engineering News where he led coverage of COVID vaccines, gene editing, and all things RNA. His work has also appeared in MIT Technology Review, Science, STAT, and more. Ryan is a graduate of Boston University's master's program in science journalism, and he studied genetics, neuroscience, and medicinal chemistry at Purdue University. He is from Indiana and currently lives in Cambridge, Massachusetts.